AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 11 min read$NCSM

Nipper Robert sold (to issuer) 36,676 shares of NCSM

Nipper Robert sold (to issuer) 36,676 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · Nipper Robert
Published Sep 1, 2026, 1:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NCSM
Bearish
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMBearishLow
01

Why it matters

The filing provides the first public disclosure of the director's complete exit from NCSM, offering a data point for investors.

02

Market read

Insider sell may modestly affect NCSM's stock price; limited broader market impact.

03

What to watch

No price disclosed; holdings after sale are zero, indicating complete exit.

Relevance 4/10Novelty 4/10Timing: reported on 2026-09-01

Background

Form 4 filings disclose insider transactions; director sales are monitored for potential signals.

Company-level read

Ticker impact

$NCSMBearishMedium confidence
Context

Director Robert Nipper sold 36,676 shares of NCS Multistage Holdings in a Form 4 filing.

Expected impact

Potential short-term dip of 1-2% as market digests insider sell.

Evidence & confidence

Sale size is modest relative to float and no price disclosed; impact limited but could influence sentiment.

Market effects

Sector

Minimal effect on the broader biotech/healthcare sector.

Regional

Limited to US markets where NCSM trades.

Global

Low

Counterpoint

What could challenge this read

Insider sale may be routine portfolio rebalancing, not a red flag.

Key entities

  • Company
    NCS Multistage Holdings, Inc.

    US-listed biotech firm (ticker NCSM).

  • Individual
    Robert Nipper

    Director of NCSM who sold his shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NCSM insider trading history →

Related articles

SEP 21
$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).

SEC EDGAR1 min